A scenario modelling analysis to anticipate the impact of COVID-19 vaccination in adolescents and children on disease outcomes in the Netherlands, summer 2021

Author:

Ainslie Kylie E C123ORCID,Backer Jantien A3ORCID,de Boer Pieter T3ORCID,van Hoek Albert Jan3ORCID,Klinkenberg Don3ORCID,Korthals Altes Hester3ORCID,Leung Ka Yin3ORCID,de Melker Hester3ORCID,Miura Fuminari43ORCID,Wallinga Jacco53ORCID

Affiliation:

1. MRC Centre for Global Infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, United Kingdom

2. School of Public Health, Imperial College London, London, United Kingdom

3. Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands

4. Center for Marine Environmental Studies (CMES), Ehime University, Ehime, Japan

5. Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands

Abstract

Background Since the roll-out of COVID-19 vaccines in late 2020 and throughout 2021, European governments have relied on mathematical modelling to inform policy decisions about COVID-19 vaccination. Aim We present a scenario-based modelling analysis in the Netherlands during summer 2021, to inform whether to extend vaccination to adolescents (12–17-year-olds) and children (5–11-year-olds). Methods We developed a deterministic, age-structured susceptible-exposed-infectious-recovered (SEIR) model and compared modelled incidences of infections, hospital and intensive care admissions, and deaths per 100,000 people across vaccination scenarios, before the emergence of the Omicron variant. Results Our model projections showed that, on average, upon the release of all non-pharmaceutical control measures on 1 November 2021, a large COVID-19 wave may occur in winter 2021/22, followed by a smaller, second wave in spring 2022, regardless of the vaccination scenario. The model projected reductions in infections/severe disease outcomes when vaccination was extended to adolescents and further reductions when vaccination was extended to all people over 5 years-old. When examining projected disease outcomes by age group, individuals benefitting most from extending vaccination were adolescents and children themselves. We also observed reductions in disease outcomes in older age groups, particularly of parent age (30–49 years), when children and adolescents were vaccinated, suggesting some prevention of onward transmission from younger to older age groups. Conclusions While our scenarios could not anticipate the emergence/consequences of SARS-CoV-2 Omicron variant, we illustrate how our approach can assist decision making. This could be useful when considering to provide booster doses or intervening against future infection waves.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference39 articles.

1. Ritchie M, Rodés-Guirao A, Giattino O-O, et al. Coronavirus Pandemic (COVID-19). Our World in Data. Available from: https://ourworldindata.org/coronavirus

2. Data-Centric Epidemic Forecasting: A Survey.;Rodríguez,2022

3. Ainslie K, Backer J, van Hoek AJ, Klinkenberg D, McDonald S, Miura F, et al. The expected outcome of COVID-19 vaccination strategies. Rijksinstituut voor Volksgezondheid en Milieu (RIVM); 2021 Aug. Available from: https://www.rivm.nl/documenten/expected-outcome-of-covid-19-vaccination-strategies

4. covid19-scenario-modeling-hub: COVID-19 Scenario Modeling Hub. Github; Available from: https://github.com/midas-network/covid19-scenario-modeling-hub

5. Scenario modelling to support industry strategic planning and decision making.;Greiner;Environ Model Softw,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3